Zhejiang Medicine , Ltd. Profit Margin

As of the most recent data (September 2026), 600216.SS shows a profit margin of 7.51%. That compares with 13.89% in the prior-year period — down 45.9% year over year. That is below the sector sector average of 13.23%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 600216.SS's profit margin is now 7.51% (was 13.89%) — a 45.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Zhejiang Medicine , Ltd. is outperforming or lagging.

The its sector sector average profit margin is about 13.23%. Zhejiang Medicine , Ltd. is at 7.51%, which is lower that average. That is roughly 43.2% below the sector mean. Use the comparison chart on this page to see how 600216.SS stacks up against individual peers as well.

That compares with 13.89% in the prior-year period — down 45.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Zhejiang Medicine , Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Zhejiang Medicine , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 7.51%) with ownership activity and broader fundamentals.